Liver disease associated with alpha1-antitrypsin deficiency (Q35960853)

11 August 2017

1 reference

title

Liver disease associated with alpha1-antitrypsin deficiency (English)

1 reference

11 August 2017

1 reference

Rosen HR

1

1 reference

11 August 2017

publication date

1 February 1998

1 reference

11 August 2017

published in

Clinics in liver disease

1 reference

11 August 2017

volume

2

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

175-185

1 reference

Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Acetaldehyde inhibits the anti-elastase activity of alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

The pathologic spectrum of the nephropathy associated with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

HLA phenotypes and gene polymorphisms in juvenile liver disease associated with α1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Retroviral-mediated gene transfer into hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Liver transplantation for end-stage liver disease associated with alpha-1-antitrypsin deficiency in children: pretransplant natural history, timing and results of transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Increased intestinal clearance of alpha 1-antitrypsin in patients with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

The fetal liver in PiZZ alpha-1-antitrypsin deficiency: a report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Indications for and timing of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 Infants

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Psychological consequences of neonatal screening for alpha 1 antitrypsin deficiency (ATD). Parental attitudes toward "ATD-check-ups" and parental recommendations regarding future screening

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Human plasma proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

TRANSPLANTATION FOR END STAGE LIVER DISEASE RELATED TO ALPHA 1 ANTITRYPSIN

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970370-6

7 January 2021

10.1016/S1089-3261(05)70370-6

Identifiers

DOI

1 reference

11 August 2017

1 reference